Company: OXBRW
Filing Date: 2025-04-25
Form Type: S-3
Source: 0001641172-25-006292
Chunk: 3

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-04-25
Form: S-3
Chunk 3
---
                                          |  11 |
| RISK FACTORS.                                          |  12 |
| USE OF PROCEEDS.                                       |  13 |
| DESCRIPTION OF SECURITIES.                             |  14 |
| DILUTION.                                              |  18 |
| PLAN OF DISTRIBUTION.                                  |  19 |
| LEGAL MATTERS.                                         |  20 |
| EXPERTS.                                               |  20 |
| WHERE YOU CAN FIND MORE INFORMATION.                   |  20 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE.     |  21 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

Unless the context otherwise required, references in this prospectus to “we,” “us,” “our,” “our company,” “the Company,” or “Oxbridge” refer to Oxbridge RE Holdings Limited and Oxbridge RE Holdings Limited and its subsidiaries, SurancePlus Holdings Ltd., SurancePlus Inc., Oxbridge Re NS, DSN Blockchain Technologies Ltd. and Oxbridge Reinsurance Limited.

This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission (the “SEC”), using a “shelf” registration process. This prospectus relates to the offering of ordinary shares issuable upon the exercise of the outstanding Warrants. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to this offering. The free writing prospectus may also add, update or change information contained in this prospectus with respect to this offering. If there is any inconsistency between the information in this prospectus and the free writing prospectus, you should rely on the free writing prospectus, as applicable. Before exercising any Warrants for ordinary shares covered by this prospectus, you should carefully read this prospectus (and any applicable free writing prospectuses), together with the additional information described under the heading “Where You Can Find More Information; Incorporation of Certain Information by Reference.”

We have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We will not issue ordinary shares upon exercise of outstanding Warrants in any jurisdiction where offers or sales are not permitted. You should assume that